Skip to main content

Oncology Startups

Updated August 2026

Companies in the oncology sector developing innovative solutions and technologies.

Explore 303 recently funded oncology companies with verified founder contact information and fundraising data.

Total Companies
303
Total Funding
$995.3M
Avg Funding
$39.8M
Global Reach
6
countries

Top Cities for Oncology

London
Baltimore
South San Francisco
Cambridge
Palo Alto
Paris

Recently Funded Companies

Export
London, United Kingdom

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

$13.4M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Baltimore, United States

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

$4.5M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Earli develops genetic constructs for early cancer detection and targeted therapy.

Aug 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

$120.0M raised
Aug 2024

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Valar Labs offers assistance services for cancer treatment through Artificial Intelligence.

$22.0M raised
May 2024

Founder Contacts

41,000+ verified contacts

Paris, France

Resilience provides remote patient care monitoring to help improve cancer patients' quality of life and overall survival.

$25.0M raised
May 2024

Founder Contacts

41,000+ verified contacts

Berlin, Germany

The Operating System for Human Breakthroughs.

$1.3M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Seattle, United States

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

$112.0M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Orsay, France

Hephaistos Pharma is a biotech company developing oncology treatments.

$4.9M raised
Jan 2024

Founder Contacts

41,000+ verified contacts

Edinburgh, United Kingdom

Cumulus Oncology develops anti-cancer therapies for clinical settings in areas of high unmet need.

$11.5M raised
Jan 2024

Founder Contacts

41,000+ verified contacts

New York, United States

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

$100.0M raised
Jan 2024

Founder Contacts

41,000+ verified contacts

Yongsan, South Korea

Kanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.

$17.8M raised
Dec 2023

Founder Contacts

41,000+ verified contacts

Wilmington, United States

Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.

$102.0M raised
Dec 2023

Founder Contacts

41,000+ verified contacts

Medford, United States

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

$10.0M raised
Oct 2023

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

$5.0M raised
Oct 2023

Founder Contacts

41,000+ verified contacts

Plymouth Meeting, United States

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

$5.0M raised
Sep 2023

Founder Contacts

41,000+ verified contacts

Watertown, United States

Mariana Oncology is a biotechnology research industry.

$175.0M raised
Sep 2023

Founder Contacts

41,000+ verified contacts

California City, United States

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

$52.5M raised
Aug 2023

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

$20.0M raised
Aug 2023

Founder Contacts

41,000+ verified contacts

Seattle, United States

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

$14.0M raised
May 2023

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

$8.0M raised
May 2023

Founder Contacts

41,000+ verified contacts

Boston, United States

Xsphera Biosciences is a biotechnology startup that focuses on delivering functional, precision immuno-oncology solutions.

$12.6M raised
May 2023

Founder Contacts

41,000+ verified contacts

Greensboro, United States

Fuse Oncology provides business and clinical intelligence solution for radiation oncology.

$8.9M raised
Apr 2023

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

$142.0M raised
Apr 2023

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Droplet Biosciences can offer earlier and more accurate cancer diagnosis by using lymphatic fluid.

$8.0M raised
Mar 2023

Founder Contacts

41,000+ verified contacts

Showing 201 to 225 of 303 companies

About the Oncology Startup Ecosystem

The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Oncology

Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Oncology Funding Breakdown

Here is how funding is distributed among the 303 oncology companies tracked in the VCBacked database.

Average Funding
$39.8M
Total Funding Tracked
$995.3M
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Oncology

1.Cambridge
4 companies$156.0M
2.Seattle
2 companies$126.0M
3.London
1 companies$13.4M
4.Baltimore
1 companies$4.5M
5.South San Francisco
1 companiesUndisclosed

Related Industries

Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Oncology Startups?

Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked